BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Credit Suisse Maintains Hold on Cadila Healthcare
Credit Suisse maintained its 'neutral' rating on Cadila Healthcare for target price of Rs 1,800 per share. Credit Suisse says 'neutral' stance is because they are awaiting clarity on 483 observations on Moraiya facility. Credit Suisse expects tax rate to reduce with new structure and has raised FY16 earnings per share by 8 per cent.